Siloam Vision, Inc.
Lake Oswego, OR · Founded 2021 · CIK 0002087423 · Medtech · Private
AI software algorithm for automated diagnosis of retinopathy of prematurity (ROP) from retinal images
siloamvision.com →- Grants
- $2.8M
- 3 awards
- Sector median: 1
- Raised
- $3.2M
- 5 Form D · Jan 2026
- 8 months since last filing
- Contracts
- $1.2M
- 1 award · Defense
- #287 of 4531 in medtech
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Validation of artificial intelligence (AI) based software as medical device (SaMD) for retinopathy of prematurity (ROP) | $1,907,135 | |
| Federal grant | Department of Health and Human Services · Phase II · Validation of artificial intelligence (AI) based software as medical device (SaMD) for retinopathy of prematurity (ROP) | $52,865 | |
| Federal grant | Department of Health and Human Services · Phase II · Ultrawide field non-mydriatic portable pediatric retinal imaging | $881,796 | |
| Federal contract | Department of Defense · Advanced Ultra-widefield Retinal Imaging With Ai-analytics For Detection Of Debilitating Ocular Pathologies In The Field For Pilots And Other Military Personnel | $1,249,151 | |
| Private capital raised· 1 of 4 same day | Form D · SEC | $745,000 | |
| Private capital raised· 2 of 4 same day | Form D · SEC | $1,085,000 | |
| Private capital raised· 3 of 4 same day | Form D · SEC | $550,000 | |
| Private capital raised· 4 of 4 same day | Form D · SEC | $500,000 | |
| Private capital raised | Form D · SEC | $350,000 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 284 | INTELLIGENT HEARING SYSTEMS | $1.3M | — |
| 285 | DXLAB INC | $1.2M | $4.0M |
| 286 | XSONX, LLC | $1.2M | — |
| 287 | Siloam Vision, Inc. | $1.2M | $3.2M |
| 288 | COURTESY CUPS, LLC | $1.2M | — |
| 289 | Cheetah Medical | $1.2M | $40M |
| 290 | Genalyte | $1.2M | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- John CampbellDirector · Executive Officer
- Karyn JonasExecutive Officer
- Robison Vernon Paul ChanExecutive Officer
- Tong SunExecutive Officer
- Degang WangExecutive Officer
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.